{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:18:43Z","timestamp":1788171523809,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.7759\/cureus.115487","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:01:57Z","timestamp":1788170517000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Actionability: A Real-World Audit and Quality Improvement Initiative to Refine Shared Decision-Making Following 50-Gene Next-Generation Sequencing Results in Non-small Cell Lung Cancer"],"prefix":"10.7759","author":[{"given":"Arun","family":"Krishnan M.P.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyshakh","family":"Thovarayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen K","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Devi R.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Roshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-025-00801-x","article-title":"Update 2025: management of non\u2011small-cell lung cancer","volume":"203","author":"Jeon H","year":"2025","unstructured":"Jeon H, Wang S, Song J, Gill H, Cheng H. Update 2025: management of non\u2011small-cell lung cancer. Lung. 2025, 203:53. 10.1007\/s00408-025-00801-x","journal-title":"Lung"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207490","article-title":"Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing","volume":"75","author":"Conde E","year":"2022","unstructured":"Conde E, Rojo F, G\u00f3mez J, et al.. Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing. J Clin Pathol. 2022, 75:145-53. 10.1136\/jclinpath-2021-207490","journal-title":"J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/GO-24-00587","article-title":"Comprehensive genomic profiling of Indian patients with lung cancer","volume":"11","author":"Sharma S","year":"2025","unstructured":"Sharma S, Noronha V, Yadav A, et al.. Comprehensive genomic profiling of Indian patients with lung cancer. JCO Glob Oncol. 2025, 11:2400587. 10.1200\/GO-24-00587","journal-title":"JCO Glob Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.3130","article-title":"Increasing targeted therapy options for patients with relapsed cancer with broader somatic gene panel analysis from the primary tumor: the Profiler02 randomized phase II trial","volume":"40","author":"Tredan O","year":"2022","unstructured":"Tredan O, Damien P, Nicolas P, et al.. Increasing targeted therapy options for patients with relapsed cancer with broader somatic gene panel analysis from the primary tumor: the Profiler02 randomized phase II trial. J Clin Oncol. 2022, 40:3130. 10.1200\/JCO.2022.40.16_suppl.3130","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01816-9","article-title":"Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions","volume":"16","author":"Ghoreyshi N","year":"2025","unstructured":"Ghoreyshi N, Heidari R, Farhadi A, Chamanara M, Farahani N, Vahidi M, Behroozi J. Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions. Discov Oncol. 2025, 16:578. 10.1007\/s12672-025-01816-9","journal-title":"Discov Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2024.07.011","article-title":"Landscape of clinically relevant genomic alterations in the Indian non-small cell lung cancer patients","volume":"25","author":"Jha P","year":"2024","unstructured":"Jha P, Joshi A, Mishra R, et al.. Landscape of clinically relevant genomic alterations in the Indian non-small cell lung cancer patients. Clin Lung Cancer. 2024, 25:420-30. 10.1016\/j.cllc.2024.07.011","journal-title":"Clin Lung Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li MM","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, et al.. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017, 19:4-23. 10.1016\/j.jmoldx.2016.10.002","journal-title":"J Mol Diagn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076164","article-title":"Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity","volume":"8","author":"Chougule A","year":"2013","unstructured":"Chougule A, Prabhash K, Noronha V, et al.. Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity. PLoS One. 2013, 8:76164. 10.1371\/journal.pone.0076164","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-099134","article-title":"Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study","volume":"15","author":"De Micheli V","year":"2025","unstructured":"De Micheli V, Agnelli L, Conca E, et al.. Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study. BMJ Open. 2025, 15:099134. 10.1136\/bmjopen-2025-099134","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_653_22","article-title":"Frequency of EGFR mutations in lung adenocarcinoma patients - a study from tertiary cancer center of South India","volume":"19","author":"Nayanar SK","year":"2023","unstructured":"Nayanar SK, Mohan A, Shenoy P, Saravanan M, Gopinath V, Deepak Roshan VG. Frequency of EGFR mutations in lung adenocarcinoma patients - a study from tertiary cancer center of South India. J Cancer Res Ther. 2023, 19:712-8. 10.4103\/jcrt.jcrt_653_22","journal-title":"J Cancer Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00092","article-title":"Clinical utility of tumor next-generation sequencing panel testing to inform treatment decisions for patients with advanced solid tumors in a tertiary care center","volume":"8","author":"Bogdan L","year":"2024","unstructured":"Bogdan L, Saleh RR, Avery L, Del Rossi S, Yu C, Bedard PL. Clinical utility of tumor next-generation sequencing panel testing to inform treatment decisions for patients with advanced solid tumors in a tertiary care center. JCO Precis Oncol. 2024, 8:2400092. 10.1200\/PO.24.00092","journal-title":"JCO Precis Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051121","article-title":"Clinical utility of next-generation sequencing-based panel testing under the universal health-care system in Japan: a retrospective analysis at a single University Hospital","volume":"13","author":"Inagaki C","year":"2021","unstructured":"Inagaki C, Maeda D, Hatake K, et al.. Clinical utility of next-generation sequencing-based panel testing under the universal health-care system in Japan: a retrospective analysis at a single University Hospital. Cancers (Basel). 2021, 13:2021-13. 10.3390\/cancers13051121","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2020.03.001","article-title":"Involving patients and their families in deciding to use next generation sequencing: results from a nationally representative survey of U.S. oncologists","volume":"104","author":"Spees LP","year":"2021","unstructured":"Spees LP, Roberts MC, Freedman AN, Butler EN, Klein WM, Prabhu Das I, de Moor JS. Involving patients and their families in deciding to use next generation sequencing: results from a nationally representative survey of U.S. oncologists. Patient Educ Couns. 2021, 104:33-9. 10.1016\/j.pec.2020.03.001","journal-title":"Patient Educ Couns"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522919-beyond-actionability-a-real-world-audit-and-quality-improvement-initiative-to-refine-shared-decision-making-following-50-gene-next-generation-sequencing-results-in-non-small-cell-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:01:58Z","timestamp":1788170518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522919-beyond-actionability-a-real-world-audit-and-quality-improvement-initiative-to-refine-shared-decision-making-following-50-gene-next-generation-sequencing-results-in-non-small-cell-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.115487","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}